|
Title
|
FOA/Notice Number
|
Related |
Issuing Org
|
Released ▼
|
Opens
|
Expires
|
Activity Code
|
| AHRQ Health Services Research Project: Partners Enabling Diagnostic Excellence (R01) |
RFA-HS-19-003 |
Related |
AHRQ
| 03-22-2019 |
03-22-2019 |
05-30-2019 |
R01 |
| Cystic Fibrosis Research and Translation Centers (P30 Clinical Trial Optional) |
RFA-DK-19-003 |
Related |
NIDDK
| 03-21-2019 |
06-18-2019 |
07-19-2019 |
P30 |
| Using Data Analytics to Support Primary Care and Community Interventions to Improve Chronic Disease Prevention and Management and Population Health (R18) |
RFA-HS-19-002 |
Related |
AHRQ
| 03-20-2019 |
03-20-2019 |
05-30-2019 |
R18 |
| Maintenance and Enhancement of ISO/IEC 17025 Accreditation and Whole Genome Sequencing for State Food Testing Laboratories (U18 Clinical Trial Not Allowed) |
RFA-FD-19-018 |
Related |
FDA
| 03-19-2019 |
03-22-2019 |
05-22-2019 |
U18 |
| Research Project Grants in Pediatric Rehabilitation (R01 Clinical Trial Optional) |
RFA-HD-20-005 |
Related |
NICHD
| 03-18-2019 |
05-27-2019 |
06-28-2019 |
R01 |
| Atopic Dermatitis Research Network -Clinical Research Centers (U01 Clinical Trial Optional) |
RFA-AI-19-015 |
Related |
NIAID
| 03-18-2019 |
06-07-2019 |
07-09-2019 |
U01 |
| Atopic Dermatitis Research Network Leadership Center (UM1) Clinical Trial Required |
RFA-AI-19-014 |
Related |
NIAID
| 03-18-2019 |
06-07-2019 |
07-09-2019 |
UM1 |
| U.S.-South Africa Program for Collaborative Biomedical Research - Phase 2 (HIV/AIDS) (U01 Clinical Trial Optional) |
RFA-AI-19-023 |
Related |
NIAID
| 03-15-2019 |
06-26-2019 |
07-27-2019 |
U01 |
| U.S.-South Africa Program for Collaborative Biomedical Research - Phase 2 (Infectious Diseases) (U01 Clinical Trial Optional) |
RFA-AI-19-025 |
Related |
NIAID
| 03-15-2019 |
06-26-2019 |
07-27-2019 |
U01 |
| U.S.-South Africa Program for Collaborative Biomedical Research - Phase 2 (Infectious Diseases) (R01 Clinical Trial Optional) |
RFA-AI-19-024 |
Related |
NIAID
| 03-15-2019 |
06-26-2019 |
07-27-2019 |
R01 |
| U.S.-South Africa Program for Collaborative Biomedical Research - Phase 2 (HIV/AIDS) (R01 Clinical Trial Optional) |
RFA-AI-19-022 |
Related |
NIAID
| 03-15-2019 |
06-26-2019 |
07-27-2019 |
R01 |
| Silvio O. Conte Digestive Diseases Research Core Centers (P30 Clinical Trial Optional) |
RFA-DK-19-004 |
Related |
NIDDK
| 03-13-2019 |
10-01-2019 |
07-02-2021 |
P30 |
| Nutrition Obesity Research Centers (NORCs) (P30 Clinical Trial Optional) |
RFA-DK-19-002 |
Related |
NIDDK
| 03-13-2019 |
09-23-2019 |
06-03-2020 |
P30 |
| Feasibility and Planning Studies for Development of Specialized Programs of Research Excellence (SPOREs) to Investigate Cancer Health Disparities (P20 Clinical Trial Optional) |
RFA-CA-19-034 |
Related |
NCI
| 03-13-2019 |
05-19-2019 |
10-19-2020 |
P20 |
| Medical Rehabilitation Research Resource (P2C Clinical Trial Optional) |
RFA-HD-20-004 |
Related |
NICHD
| 03-13-2019 |
03-19-2019 |
06-28-2019 |
P2C |
| Implementation of the Animal Feed Regulatory Program Standards (U18 Clinical Trial Not Allowed) |
RFA-FD-19-021 |
Related |
FDA
| 03-12-2019 |
03-19-2019 |
05-21-2019 |
U18 |
| BLOODSAFE: Research to enhance availability of safe blood for patients with severe anemia and hemorrhagic conditions in low or lower-middle income countries (LLMICs) in Sub-Saharan Africa - Data Coordinating Center (DCC) (U24 Clinical Trial Not Allowed) |
RFA-HL-20-010 |
Related |
NHLBI
| 03-11-2019 |
04-19-2019 |
05-21-2019 |
U24 |
| BLOODSAFE: Research to enhance availability of safe blood for patients with severe anemia and hemorrhagic conditions in low or lower-middle income countries (LLMICs) in Sub-Saharan Africa (UG3/UH3 Clinical Trial Optional) |
RFA-HL-20-009 |
Related |
NHLBI
| 03-11-2019 |
04-19-2019 |
05-21-2019 |
UG3/UH3 |
| Limited Competition: Dental, Oral and Craniofacial Tissue Regeneration Consortium (U24 Clinical Trial Not Allowed) |
RFA-DE-19-010 |
Related |
NIDCR
| 03-11-2019 |
05-11-2019 |
06-12-2019 |
U24 |
| Kidney Technology Development Research Education Program (R25 Clinical Trial Not Allowed) |
RFA-DK-19-006 |
Related |
NIDDK
| 03-11-2019 |
07-06-2019 |
08-07-2019 |
R25 |
| Disparities Elimination through Coordinated Interventions to Prevent and Control Heart and Lung Disease Risk (DECIPHeR) - Research Coordinating Center (RCC) (U24 Clinical Trial Not Allowed) |
RFA-HL-20-004 |
Related |
NHLBI
| 03-11-2019 |
04-17-2019 |
10-02-2019 |
U24 |
| Disparities Elimination through Coordinated Interventions to Prevent and Control Heart and Lung Disease Risk (DECIPHeR) (UG3/UH3 Clinical Trial Optional) |
RFA-HL-20-003 |
Related |
NHLBI
| 03-11-2019 |
04-17-2019 |
10-02-2019 |
UG3/UH3 |
| Limited Competition for the Continuation of the Chronic Kidney Disease Biomarkers Consortium (CKD BioCon) Data Coordinating Center (U01 Clinical Trial Not Allowed) |
RFA-DK-19-501 |
Related |
NIDDK
| 03-08-2019 |
04-15-2019 |
05-16-2019 |
U01 |
| Functional Target Validation for Alzheimer's Disease-Related Dementias (ADRDs) (UG3/UH3 Clinical Trial Not Allowed) |
RFA-NS-19-015 |
Related |
NINDS
| 03-06-2019 |
04-06-2019 |
05-07-2019 |
UG3/UH3 |
| Geroscience Approaches to Alzheimer's Disease (R01 Clinical Trial Not Allowed) |
RFA-AG-20-013 |
Related |
NIA
| 03-05-2019 |
06-02-2019 |
07-03-2019 |
R01 |
| Geroscience Approaches to Alzheimer's Disease (R21 Clinical Trial Not Allowed) |
RFA-AG-20-014 |
Related |
NIA
| 03-05-2019 |
06-02-2019 |
07-03-2019 |
R21 |
| Emerging Infectious Diseases Research Centers (U01 Clinical Trial Not Allowed) |
RFA-AI-19-028 |
Related |
NIAID
| 03-05-2019 |
05-28-2019 |
06-29-2019 |
U01 |
| Emerging Infectious Diseases Research Centers - Coordination Center (U01 Clinical Trial Not Allowed) |
RFA-AI-19-029 |
Related |
NIAID
| 03-04-2019 |
05-28-2019 |
06-29-2019 |
U01 |
| Limited Competition: Renewal of the Aging Interventions Testing Program (U01 Clinical Trial Not Allowed) |
RFA-AG-19-030 |
Related |
NIA
| 03-01-2019 |
04-01-2019 |
05-02-2019 |
U01 |
| Interventions Testing Program Data Coordinating Center (U24 Clinical Trial Not Allowed) |
RFA-AG-19-031 |
Related |
NIA
| 03-01-2019 |
04-01-2019 |
05-02-2019 |
U24 |
| Understanding the Mechanisms of Neuropsychiatric Side Effects and Neurological Toxicities of HIV Medicines (R21 Clinical Trial Not Allowed) |
RFA-MH-20-115 |
Related |
NIMH
| 02-27-2019 |
04-02-2019 |
05-03-2019 |
R21 |
| Neuropathological Assessment of TBI-related Neurodegeneration and Neurocognitive decline - Center Without Walls (NATBI CWOW) (U54 Clinical Trial Not Allowed) |
RFA-NS-19-030 |
Related |
NINDS
| 02-25-2019 |
03-15-2019 |
04-16-2019 |
U54 |
| Clinical and Biological Measures of TBI-related dementia including Chronic Traumatic Encephalopathy (CTE) (R01 Clinical Trial Not Allowed) |
RFA-NS-19-026 |
Related |
NINDS
| 02-25-2019 |
03-15-2019 |
04-16-2019 |
R01 |
| Limited Competition: Nonhuman Primate (NHP) Radiation Survivor Cohort (RSC) (U01 Clinical Trial Not Allowed) |
RFA-AI-19-010 |
Related |
NIAID
| 02-25-2019 |
04-30-2019 |
06-01-2019 |
U01 |
| Tobacco Regulatory Science (R01 Clinical Trial Optional) |
RFA-OD-19-019 |
Related |
ODP
| 02-21-2019 |
06-19-2019 |
02-14-2021 |
R01 |
| Advancing Cancer Immunotherapy by Mitigating Immune-related Adverse Events (irAEs) (U01 Clinical Trial Not Allowed) |
RFA-CA-19-044 |
Related |
NCI
| 02-20-2019 |
03-25-2019 |
04-26-2019 |
U01 |
| Development, Implementation, and Management of a Funding System to support the Grade A Milk Safety Program and National Shellfish Sanitation Program (U18) |
RFA-FD-19-004 |
Related |
FDA
| 02-19-2019 |
03-01-2019 |
05-01-2019 |
U18 |
| Development of Standard Core Clinical Outcomes Assessments (COAs) and Endpoints (UG3/UH3 Clinical Trial Optional) |
RFA-FD-19-006 |
Related |
FDA
| 02-19-2019 |
03-01-2019 |
06-01-2019 |
UG3/UH3 |
| Post-Stroke Vascular Contributions to Cognitive Impairment and Dementia (VCID) in the United States Including in Health Disparities Populations (U19 Clinical Trial not Allowed) |
RFA-NS-19-012 |
Related |
NINDS
| 02-15-2019 |
03-17-2019 |
04-18-2019 |
U19 |
| Enhancing Regulatory Science for the Risk Based Quality Assessment of Complex Products (U01) - Clinical Trials Optional |
RFA-FD-19-011 |
Related |
FDA
| 02-13-2019 |
02-19-2019 |
04-23-2019 |
U01 |
| Cooperative Agreement to Support the Illinois Institute of Technology's Institute for Food Safety and Health (U19 Clinical Trial Optional) |
RFA-FD-19-003 |
Related |
FDA
| 02-12-2019 |
02-19-2019 |
04-22-2019 |
U19 |
| Functional RNA Modifications Environment and Disease (FRAMED) (R01 Clinical Trial Not Allowed) |
RFA-ES-19-001 |
Related |
NIEHS
| 02-08-2019 |
04-16-2019 |
05-17-2019 |
R01 |
| Functional RNA Modifications Environment and Disease (FRAMED) (R21 Clinical Trial Not Allowed) |
RFA-ES-19-002 |
Related |
NIEHS
| 02-08-2019 |
04-16-2019 |
05-17-2019 |
R21 |
| Centers for Medical Countermeasures Against Radiation Consortium (U19 Clinical Trial Not Allowed) |
RFA-AI-19-012 |
Related |
NIAID
| 02-08-2019 |
04-30-2019 |
06-01-2019 |
U19 |
| Innovative Approaches for Improving Environmental Health Literacy (R43/R44 Clinical Trial Not Allowed) |
RFA-ES-19-005 |
Related |
NIEHS
| 02-08-2019 |
03-09-2019 |
04-10-2019 |
R43/R44 |
| Innovative Approaches for Improving Environmental Health Literacy (R41/R42 Clinical Trial Not Allowed) |
RFA-ES-19-006 |
Related |
NIEHS
| 02-08-2019 |
03-09-2019 |
04-10-2019 |
R41/R42 |
| Biological Measures for Prognosing and Monitoring of Persistent Concussive Symptoms in Early and Middle Adolescents: Center Without Walls (PCS-EMA CWOW) (U54 Clinical Trial Not Allowed) |
RFA-NS-19-022 |
Related |
NINDS
| 02-07-2019 |
03-10-2019 |
04-11-2019 |
U54 |
| Bioequivalence of Topical Products: Evaluating the Cutaneous Pharmacokinetics of Topical Drug Products Using Pharmacokinetic Tomography (U01 Clinical Trial Not Allowed) |
RFA-FD-19-010 |
Related |
FDA
| 02-07-2019 |
02-11-2019 |
04-12-2019 |
U01 |
| Bioequivalence of Topical Products: Elucidating the Sensorial and Functional Characteristics of Compositionally Different Topical Formulations (U01 Clinical Trial Required) |
RFA-FD-19-009 |
Related |
FDA
| 02-07-2019 |
02-11-2019 |
04-12-2019 |
U01 |
| Bioequivalence of Topical Products: Bioequivalence Considerations for Ungual, Scalp, Vaginal, Anal or Rectal Dosage Forms (U01 Clinical Trial Not Allowed) |
RFA-FD-19-008 |
Related |
FDA
| 02-07-2019 |
02-11-2019 |
04-12-2019 |
U01 |
| Patient Reported Outcomes Tool Development for Use in Non-Cystic Fibrosis Bronchiectasis Clinical Trials (U01- Clinical Trial Required) |
RFA-FD-19-014 |
Related |
FDA
| 02-06-2019 |
02-06-2019 |
04-05-2019 |
U01 |
| Secondary Data Analysis to Examine Long-Term and/or Potential Cross-Over Effects of Prevention Interventions: What are the Benefits for Preventing Mental Health Disorders? (R01 Clinical Trial Not Allowed) |
RFA-MH-20-110 |
Related |
NIMH
| 02-06-2019 |
04-02-2019 |
01-03-2020 |
R01 |
| Refinement and Testing of Interventions to Sustain ADHD Treatment Effects Across Settings and Developmental Transitions (R34 Clinical Trial Required) |
RFA-MH-20-100 |
Related |
NIMH
| 02-04-2019 |
04-01-2019 |
11-16-2019 |
R34 |
| NCI Awardee Skills Development Consortium: Research Education Short Courses (UE5 Clinical Trial Not Allowed) |
RFA-CA-19-010 |
Related |
NCI
| 02-01-2019 |
03-01-2019 |
04-02-2019 |
UE5 |
| NCI Awardee Skills Development Consortium: Program Logistics and Evaluation Coordinating Center (U24 Clinical Trial Not Allowed) |
RFA-CA-19-011 |
Related |
NCI
| 02-01-2019 |
03-01-2019 |
04-02-2019 |
U24 |
| George M. O'Brien Urology Cooperative Research Centers Program (U54 Clinical Trial Optional) |
RFA-DK-18-029 |
Related |
NIDDK
| 01-31-2019 |
03-24-2019 |
04-25-2019 |
U54 |
| Multidisciplinary K12 Urologic Research (KURe) Career Development Program (K12 Clinical Trial Optional) |
RFA-DK-18-027 |
Related |
NIDDK
| 01-31-2019 |
03-24-2019 |
04-25-2019 |
K12 |
| Patient Safety Learning Laboratories (2019): Pursuing Safety in Diagnosis and Treatment at the Intersection of Design, Systems Engineering, and Health Services Research (R18) |
RFA-HS-19-001 |
Related |
AHRQ
| 01-31-2019 |
01-31-2019 |
04-01-2019 |
R18 |
| Computational Models of Immunity (U01 Clinical Trial Not Allowed) |
RFA-AI-19-011 |
Related |
NIAID
| 01-30-2019 |
05-10-2019 |
06-11-2019 |
U01 |
| High Quality Human Reference Genomes (HQRG) (U01 Clinical Trial Not Allowed) |
RFA-HG-19-002 |
Related |
NHGRI
| 01-30-2019 |
03-02-2019 |
04-03-2019 |
U01 |
| Human Genome Reference Center (HGRC) (U41 Clinical Trial Not Allowed) |
RFA-HG-19-004 |
Related |
NHGRI
| 01-30-2019 |
03-02-2019 |
04-03-2019 |
U41 |
| Research and Development for Genome Reference Representations (GRR) (U01 Clinical Trial Not Allowed) |
RFA-HG-19-003 |
Related |
NHGRI
| 01-30-2019 |
03-02-2019 |
04-03-2019 |
U01 |
| Addressing the Role of Violence on HIV Care and Viral Suppression (R34 Clinical Trial Optional) |
RFA-MH-20-202 |
Related |
NIMH
| 01-29-2019 |
03-10-2019 |
04-11-2019 |
R34 |
| Addressing the Role of Violence on HIV Care and Viral Suppression (R21 Clinical Trial Optional) |
RFA-MH-20-201 |
Related |
NIMH
| 01-29-2019 |
03-10-2019 |
04-11-2019 |
R21 |
| Addressing the Role of Violence on HIV Care and Viral Suppression (R01 Clinical Trial Optional) |
RFA-MH-20-200 |
Related |
NIMH
| 01-29-2019 |
03-10-2019 |
04-11-2019 |
R01 |
| Developmental Centers for Interdisciplinary Research in Benign Urology (P20 Clinical Trial Not Allowed) |
RFA-DK-18-028 |
Related |
NIDDK
| 01-29-2019 |
03-10-2019 |
04-11-2019 |
P20 |
| Validating Human Stem Cell Cardiomyocyte Technology for Better Predictive Assessment of Drug-Induced Cardiac Toxicity (U01 Clinical Trial Not Allowed) |
RFA-FD-19-002 |
Related |
FDA
| 01-29-2019 |
02-04-2019 |
04-05-2019 |
U01 |
| Advanced Clinical Trials to test Artificial Pancreas Device Systems in Type 1 Diabetes (U01 Clinical Trial Required) |
RFA-DK-18-025 |
Related |
NIDDK
| 01-28-2019 |
03-10-2019 |
04-11-2019 |
U01 |
| Data Coordinating Center for the Advanced Clinical Trials Consortium to Test Artificial Pancreas Device Systems (U24 Clinical Trial Not Allowed) |
RFA-DK-18-026 |
Related |
NIDDK
| 01-28-2019 |
03-10-2019 |
04-11-2019 |
U24 |
| The KUH Predoctoral to Postdoctoral Fellow Transition Award (F99/K00 Clinical Trial Not Allowed) |
RFA-DK-18-024 |
Related |
NIDDK
| 01-28-2019 |
03-10-2019 |
11-21-2019 |
F99/K00 |
| Limited Competition for a Connectome Coordination Facility (R24 Clinical Trial Not Allowed) |
RFA-MH-20-210 |
Related |
NIMH
| 01-25-2019 |
05-24-2019 |
06-25-2019 |
R24 |
| NHLBI Emerging Investigator Award (EIA) (R35 Clinical Trial Optional) |
RFA-HL-20-012 |
Related |
NHLBI
| 01-25-2019 |
02-14-2019 |
04-16-2021 |
R35 |
| NHLBI Outstanding Investigator Award (OIA) (R35 Clinical Trial Optional) |
RFA-HL-20-011 |
Related |
NHLBI
| 01-25-2019 |
02-14-2019 |
04-16-2021 |
R35 |
| Mechanistic studies on chronic alcohol use and sleep homeostasis (R01 Clinical Trial Optional) |
RFA-AA-19-006 |
Related |
NIAAA
| 01-24-2019 |
03-17-2019 |
04-18-2019 |
R01 |
| Provocative Questions (PQs) in Cancer with an Underlying HIV Infection (R01 Clinical Trial Optional) |
RFA-CA-19-032 |
Related |
NCI
| 01-24-2019 |
07-01-2019 |
08-04-2020 |
R01 |
| HIV Vaccines Clinical Trials Network Leadership and Operations Center (UM1 Clinical Trial Required) |
RFA-AI-19-006 |
Related |
NIAID
| 01-24-2019 |
07-01-2019 |
08-02-2019 |
UM1 |
| HIV/AIDS Clinical Trials Networks Laboratory Centers (UM1 Clinical Trial Required) |
RFA-AI-19-001 |
Related |
NIAID
| 01-24-2019 |
07-01-2019 |
08-02-2019 |
UM1 |
| HIV Prevention Clinical Trials Network Leadership and Operations Center (UM1 Clinical Trial Required) |
RFA-AI-19-005 |
Related |
NIAID
| 01-24-2019 |
07-01-2019 |
08-02-2019 |
UM1 |
| HIV/AIDS Maternal, Adolescent and Pediatric Therapeutics Clinical Trials Network Leadership and Operations Center (UM1 Clinical Trial Required) |
RFA-AI-19-004 |
Related |
NIAID
| 01-24-2019 |
07-01-2019 |
08-02-2019 |
UM1 |
| HIV/AIDS Adult Therapeutics Clinical Trials Network Leadership and Operations Center (UM1 Clinical Trial Required) |
RFA-AI-19-003 |
Related |
NIAID
| 01-24-2019 |
07-01-2019 |
08-02-2019 |
UM1 |
| HIV/AIDS Clinical Trials Networks Statistical and Data Management Centers (SDMC) (UM1 Clinical Trial Required) |
RFA-AI-19-002 |
Related |
NIAID
| 01-24-2019 |
07-01-2019 |
08-02-2019 |
UM1 |
| Mass Spectrometric Assays for the Reliable and Reproducible Detection of Proteins/Peptides of Importance in Obesity Research (U01 Clinical Trial Not Allowed) |
RFA-DK-19-001 |
Related |
NIDDK
| 01-23-2019 |
03-17-2019 |
04-18-2019 |
U01 |
| Establishing a Cohort to Clarify Risk and Protective Factors for Neurocognitive Complications of Pediatric Type 1 Diabetes (T1D) - Planning Cooperative Agreements (U34 Clinical Trial Not Allowed) |
RFA-DK-18-007 |
Related |
NIDDK
| 01-23-2019 |
03-11-2019 |
04-12-2019 |
U34 |
| Center for Natural Product Technology, Methodology, and Productivity Optimization (NP-TEMPO) (U41 Clinical Trial Not Allowed) |
RFA-AT-19-003 |
Related |
NCCIH
(formerly NCCAM)
| 01-22-2019 |
03-29-2019 |
04-30-2019 |
U41 |
| Botanical Dietary Supplements Research Centers (U19 Clinical Trial Optional) |
RFA-OD-19-001 |
Related |
ODS
| 01-22-2019 |
03-15-2019 |
04-16-2019 |
U19 |
| Natural Products NMR Open Data Exchange (NP-NODE) (U24 Clinical Trial Not Allowed) |
RFA-AT-19-002 |
Related |
NCCIH
(formerly NCCAM)
| 01-22-2019 |
03-01-2019 |
04-02-2019 |
U24 |
| Innovations for Healthy Living - Improving Minority Health and Eliminating Health Disparities (R43/R44 - Clinical Trial Optional) |
RFA-MD-19-001 |
Related |
NIMHD
| 01-18-2019 |
03-01-2019 |
04-02-2019 |
R43/R44 |
| Womens HIV Epidemiology Cohort Studies (R01 Clinical Trial Not Allowed) |
RFA-HD-19-024 |
Related |
NICHD
| 01-16-2019 |
03-04-2019 |
05-15-2019 |
R01 |
| Improving Outcomes for Pediatric, Adolescent and Young Adult Cancer Survivors (U01 Clinical Trial Required) |
RFA-CA-19-033 |
Related |
NCI
| 01-11-2019 |
02-15-2019 |
01-04-2020 |
U01 |
| The Experimental Therapeutics Clinical Trials Network (UM1 Clinical Trials Required) |
RFA-CA-19-007 |
Related |
NCI
| 01-10-2019 |
04-22-2019 |
05-23-2019 |
UM1 |
| The Experimental Therapeutics Clinical Trials Network (ETCTN) Pharmacokinetic Resource Laboratories (U24 Clinical Trials Not Allowed) |
RFA-CA-19-008 |
Related |
NCI
| 01-10-2019 |
04-22-2019 |
05-23-2019 |
U24 |
| Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P01 Clinical Trial Optional) |
RFA-CA-19-026 |
Related |
NCI
| 01-07-2019 |
02-07-2019 |
09-28-2019 |
P01 |
| Revisions for Incorporation of Novel NCI- Supported Technology to Accelerate Cancer Research (U01 Clinical Trial Optional) |
RFA-CA-19-024 |
Related |
NCI
| 01-07-2019 |
02-07-2019 |
09-28-2019 |
U01 |
| Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (R01 Clinical Trial Optional) |
RFA-CA-19-023 |
Related |
NCI
| 01-07-2019 |
02-07-2019 |
09-28-2019 |
R01 |
| Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P50 Clinical Trial Optional) |
RFA-CA-19-027 |
Related |
NCI
| 01-07-2019 |
02-07-2019 |
09-28-2019 |
P50 |
| Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U54 Clinical Trials Optional) |
RFA-CA-19-025 |
Related |
NCI
| 01-07-2019 |
02-07-2019 |
09-28-2019 |
U54 |
| Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U2C Clinical Trial Optional) |
RFA-CA-19-028 |
Related |
NCI
| 01-07-2019 |
02-07-2019 |
09-28-2019 |
U2C |
| Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research (R21 Clinical Trials Not Allowed) |
RFA-CA-19-021 |
Related |
NCI
| 01-07-2019 |
02-07-2019 |
09-28-2019 |
R21 |
| Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 Clinical Trials Not Allowed) |
RFA-CA-19-020 |
Related |
NCI
| 01-07-2019 |
02-07-2019 |
09-28-2019 |
R33 |
| Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R21 Clinical Trials Not Allowed) |
RFA-CA-19-019 |
Related |
NCI
| 01-07-2019 |
02-07-2019 |
09-28-2019 |
R21 |
NIH Staff